9.3 Exercise Considerations for Type 2 Diabetes & Metabolic Health

9.3 Exercise Considerations for Type 2 Diabetes & Metabolic Health

Type 2 diabetes mellitus (T2D) is a chronic metabolic disorder characterized by peripheral insulin resistance, compensatory hyperinsulinemia, and progressive pancreatic $\beta$-cell secretory exhaustion. In Canada, diabetes and prediabetes affect over 11 million individuals. Closely intertwined with T2D is Metabolic Syndrome, defined clinically by the presence of at least three of five cardiovascular-metabolic risk factors: abdominal obesity (elevated waist circumference), elevated resting blood pressure, elevated fasting triglycerides, reduced high-density lipoprotein (HDL) cholesterol, and elevated fasting plasma glucose.

For the CSEP-CPT, working with a client presenting with stable Type 2 diabetes requires rigorous competency in pre-exercise blood glucose assessment, acute symptom recognition, footwear and foot inspection protocols, and long-term program design.

---

Molecular Bioenergetics: Contraction-Mediated GLUT4 Translocation

To understand exercise prescription in diabetes, the trainer must contrast normal insulin signaling with contraction-mediated glucose uptake:

The Insulin-Dependent Pathway (Impaired in T2D)

Under resting conditions, circulating insulin binds to the extracellular $\alpha$-subunits of the transmembrane insulin receptor on skeletal muscle myocytes. This triggers tyrosine kinase phosphorylation of the intracellular $\beta$-subunits, recruiting and phosphorylating Insulin Receptor Substrate 1 (IRS-1). This activates phosphatidylinositol 3-kinase (PI3K) and protein kinase B (Akt), which in turn signals intracellular storage vesicles containing Glucose Transporter 4 (GLUT4) to translocate and fuse with the sarcolemma. In Type 2 diabetes, intracellular lipid accumulation (diacylglycerols and ceramides) impairs IRS-1 and Akt phosphorylation, causing peripheral insulin resistance and diminished glucose uptake.

The Contraction-Mediated Pathway (Intact in T2D)

During physical exercise, repeated skeletal muscle contractions bypass the impaired insulin signaling cascade through an entirely insulin-independent mechanism:

1. Intracellular Calcium Flux: Action potential propagation down the T-tubules stimulates calcium ($Ca^{2+}$) release from the sarcoplasmic reticulum. Elevated cytosolic calcium activates calcium/calmodulin-dependent protein kinase (CaMK).
2. AMPK Activation: Rapid ATP hydrolysis increases the intracellular ratio of adenosine monophosphate (AMP) to ATP ($AMP:ATP$). This sharp metabolic shift allosterically activates 5'-adenosine monophosphate-activated protein kinase (AMPK).
3. GLUT4 Translocation: Both CaMK and phosphorylated AMPK stimulate downstream Rab GTPase-activating proteins (AS160), directly mobilizing GLUT4 storage vesicles to fuse with the sarcolemma and T-tubule membranes.
4. Enhanced Facilitated Diffusion: Once embedded in the cell membrane, GLUT4 proteins transport extracellular glucose down its concentration gradient into the active muscle cell, where it is immediately phosphorylated by hexokinase into glucose-6-phosphate for glycolysis or glycogen synthesis.

The Clinical Window of Insulin Sensitivity

The contraction-mediated surge in sarcolemmal GLUT4 and subsequent upregulation of glycogen synthase enzyme activity enhances peripheral insulin sensitivity for 24 to 72 hours post-workout. Because this physiological benefit gradually dissipates, the CSEP-CPT must structure aerobic training so that the client has no more than 2 consecutive days without physical activity.

---

Pre-Exercise Blood Glucose Decision Algorithm & Safe Thresholds

Clients who use insulin or insulin secretagogues (such as sulfonylureas) are taught to check their own capillary glucose before and after exercise. The table below summarizes commonly taught thresholds from diabetes exercise guidance (ADA/ACSM, consistent with Diabetes Canada's definition of hypoglycemia as below 4.0 mmol/L). The client checks and treats; the trainer supports the client's own plan and does not adjust medication.

The Pre-Exercise Glycemic Decision Matrix

Managing Acute Glycemic Fluctuations: Hypoglycemia vs. Hyperglycemia

The CSEP-CPT must instantly differentiate between acute hypoglycemia and hyperglycemia in practice:

Acute Hypoglycemia Protocol ("The Rule of 15")

Hypoglycemia ($< 4.0\text{ mmol/L}$) represents the most acute, life-threatening exercise risk, occurring primarily in clients taking exogenous insulin or insulin secretagogues (such as sulfonylureas: gliclazide, glimepiride; or meglitinides: repaglinide). In contrast, clients on metformin monotherapy have a negligible risk of hypoglycemia.

• Clinical Signs & Symptoms: Adrenergic activation manifests as shakiness, tremors, cold diaphoresis, tachycardia, anxiety, and intense hunger. Neuroglycopenic signs follow as brain glucose levels fall: confusion, slurred speech, ataxia, blurred vision, dizziness, extreme lethargy, and loss of consciousness.
• The Rule of 15 Management:
  1. Halt exercise immediately and seat the client.
  2. Administer 15 to 20 grams of fast-acting simple carbohydrate (e.g., 4 chewable glucose tablets, 175 mL [3/4 cup] of fruit juice or regular non-diet soda, or 6 large jelly beans).
  3. Wait 15 minutes in a restful seated position.
  4. Re-test capillary blood glucose. If glucose remains $< 5.5\text{ mmol/L}$, repeat the administration of 15 to 20 g of carbohydrate and wait another 15 minutes.
  5. Once blood glucose reaches $\ge 5.5\text{ mmol/L}$, if the next scheduled meal is more than one hour away, provide a complex carbohydrate and protein snack (such as whole-grain crackers with cheese or peanut butter) to sustain glycemic stability.

---

Chronic Diabetic Microvascular & Macrovascular Complications

Chronic hyperglycemia causes microvascular and macrovascular complications. For a CSEP-CPT, any diabetic complication is a check on the CSEP-CPT Health Screening Tool: the client is referred for clearance or to a CSEP-CEP first. Know the modifications below because they shape the cleared program and are commonly examined.

Complications and Exercise Prescription Safeguards

---

Foot Care Protocols & Neuropathic Safeguards

Diabetic foot ulcers represent a catastrophic complication of peripheral neuropathy, frequently progressing to osteomyelitis and lower-extremity amputation. A minor skin abrasion or blister can go entirely unnoticed by a client lacking protective sensation.

The CSEP-CPT Foot Safety Protocol

1. Pre-Workout Inspection: The client must visually inspect both feet (plantar surface, heel, and interdigital web spaces) for redness, blisters, abrasions, calluses, or swelling. A mirror or family member can assist if mobility is impaired.
2. Footwear Standards: The client must wear supportive, well-cushioned athletic shoes with adequate toe-box width. High-friction shoes, worn treads, or tight fits are unacceptable. Synthetic moisture-wicking socks (polyester/acrylic blends) must be worn; 100% cotton socks should be avoided as they trap moisture against the skin.
3. Post-Workout Inspection: Immediately following training, shoes and socks must be removed for a secondary visual inspection. If any hot spots, blisters, or skin breaks are identified, the trainer must withhold weight-bearing exercise and refer the client to their podiatrist or physician.

---

Evidence-Based Exercise Prescription (FITT-VP) for Type 2 Diabetes

Clinical trials overwhelmingly indicate that combined aerobic and progressive resistance training produces greater reductions in glycated hemoglobin ($HbA_{1c}$) and greater improvements in insulin sensitivity than either modality performed alone.

Aerobic Conditioning (FITT-VP)

• Frequency: 3 to 7 days per week, with no more than 2 consecutive days without physical activity.
• Intensity: Moderate for a CSEP-CPT client: about 40% to 59% of HRR, or RPE 12 to 13 on the Borg 6–20 scale. A client with diabetes who wants vigorous exercise is referred to a CSEP-CEP or obtains physician clearance (CSEP-CPT Health Screening Tool).
• Time: At least 150 minutes per week of aerobic activity; bouts of any length count toward the total.
• Type: Rhythmic, large-muscle dynamic activities such as brisk walking, stationary cycling, low-impact aerobics, or aquatic exercise.

Progressive Resistance Training (FITT-VP)

• Frequency: 2 to 3 non-consecutive days per week.
• Intensity: Moderate, about 50% to 70% of predicted 1-RM, progressing over time as tolerated. Moderate loads stimulate muscular hypertrophy and expand the total storage volume of skeletal muscle glycogen.
• Volume: 2 to 3 sets of 10 to 15 repetitions across 8 to 10 multi-joint exercises targeting major upper- and lower-body muscle groups.
• Progression: Gradually increase resistance or repetitions to maintain progressive muscular overload; instruct continuous exhalation on exertion to prevent the Valsalva maneuver.